Gold nanoparticles protected by fluorinated ligands for 19F MRI.

Gold nanoparticles coated with fluorinated ligands (F-MPCs) present features suitable for (19)F MRI as observed from phantom experiments. Cellular uptake, by HeLa cells, and toxicity of fluorescent dye-decorated F-MPCs are presented together with their ability to bind hydrophobic molecules allowing for a potential combination of targeting, delivery and imaging features.

[1]  Patrick J. Gaffney,et al.  Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .

[2]  R. Murray,et al.  Monolayers in Three Dimensions: Synthesis and Electrochemistry of ω-Functionalized Alkanethiolate-Stabilized Gold Cluster Compounds , 1996 .

[3]  P. Rudolf,et al.  Water-soluble gold nanoparticles protected by fluorinated amphiphilic thiolates. , 2008, Journal of the American Chemical Society.

[4]  Florence Gazeau,et al.  Universal cell labelling with anionic magnetic nanoparticles. , 2008, Biomaterials.

[5]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[6]  D. Su,et al.  Towards a More Accurate Particle Size Distribution of Supported Catalyst by using HAADF‐STEM , 2011 .

[7]  Francesco Stellacci,et al.  Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. , 2008, Nature materials.

[8]  M. Lucarini,et al.  EPR study of dialkyl nitroxides as probes to investigate the exchange of solutes between the ligand shell of monolayers of protected gold nanoparticles and aqueous solutions. , 2004, Journal of the American Chemical Society.

[9]  T. Nishio,et al.  Gold nanoparticles coated with semi-fluorinated oligo(ethylene glycol) produce sub-100 nm nanoparticle vesicles without templates. , 2012, Journal of the American Chemical Society.

[10]  J. Riess,et al.  Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. , 2003, Angewandte Chemie.

[11]  Mangala Srinivas,et al.  Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes model , 2007, Magnetic resonance in medicine.

[12]  M. Battagliarin,et al.  Synthesis, characterization and properties of water-soluble gold nanoparticles with tunable core size , 2003 .

[13]  C. Gentilini,et al.  Effect of core size on the partition of organic solutes in the monolayer of water-soluble nanoparticles: an ESR investigation. , 2005, Journal of the American Chemical Society.

[14]  Hua Ai,et al.  Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.

[15]  E. Mileo,et al.  Formation of patches on 3D SAMs driven by thiols with immiscible chains observed by ESR spectroscopy. , 2009, Angewandte Chemie.

[16]  R. Jain,et al.  Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.

[17]  V. Rotello,et al.  Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. , 2009, Journal of the American Chemical Society.

[18]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[19]  J. Bulte,et al.  Fluorine (19F) MRS and MRI in biomedicine , 2011, NMR in biomedicine.

[20]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[21]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[22]  Elias Fattal,et al.  Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and 19F-MRI , 2009, Pharmaceutical Research.